A new method to standardize the reporting of radiation dose volumes in the use of four-dimensional computed tomography can lead to a more accurate radiation dose to the lung in lung cancers, thereby lowering the risk of lung injury.
Contrary to previous studies, African-American women with early-stage breast cancer who have surgery to remove the cancer (lumpectomy) followed by radiation therapy have a higher chance of their cancer coming back in the breast and lymph nodes 10 years after diagnosis, compared to their Caucasian counterparts, according to the largest study of its kind, presented at a scientific session October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients - pulmonary fibrosis, thereby extending patients' lives and improving their quality of life.
Over four times as many patients with a rapidly fatal type of brain cancer, glioblastoma multiforme (GBM), who are treated with the chemotherapy drug temozolomide (TMZ) and radiation therapy, can live for four years after diagnosis, compared to those who receive only radiation treatment, according to updated results of a large, international trial presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Patients with prostate cancer who receive high-dose radiation treatment and also take statin drugs commonly used to lower cholesterol have a 10 percent higher chance of being cured of their cancer at 10 years after diagnosis (76 percent), compared to those who don't take these medications (66 percent), according to a study presented at a scientific session October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Radiation seed implants (brachytherapy) are just as effective at curing prostate cancer in younger men (aged 60 and younger) as they are in older men, according to a study presented at a scientific session on October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Exercise may reduce, and even reverse, bone loss caused by hormone and radiation therapies used in the treatment of localized prostate cancer, thereby decreasing the potential risk of bone fractures and improving quality of life for these men.
Volunteers who guide low-income and minority cancer patients through cancer treatment, called lay patient navigators (LPN), help them to overcome major obstacles that prevent them from receiving quality care and achieving better outcomes, according to a study presented October 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Although Spanish-speaking cancer patients are rapidly increasing their search for patient education resources on the Internet, there are very few Spanish-language Web sites available to provide this information, according to a study presented October 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Although flu and pneumonia can be lethal for cancer patients, more than one quarter of patients undergoing radiation therapy are not complying with national guidelines to be vaccinated against these potentially life-threatening yet preventable illnesses, according to a study presented October 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
The American Society for Therapeutic Radiology and Oncology is pleased to announce that His Excellency Tabaré Vázquez, M.D., President of the Oriental Republic of Uruguay, will present a special guest lecture at ASTRO's 49th Annual Meeting to be held October 28-November 1 in Los Angeles. Dr. Vásquez, who is a radiation oncologist by training and specializes in breast cancer treatment, will speak October 30 at 9:00 a.m. at the Los Angeles Convention Center on the impact of cancer on the social arena.
As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Therapeutic Radiology and Oncology (ASTRO) is partnering with The Wellness Community "“ South Bay Cities to raise awareness of cancer survivorship issues.
As part of its continued effort to give back to the cancer communities in the cities visited during its annual scientific meeting, the Fairfax, Virginia-based American Society for Therapeutic Radiology and Oncology (ASTRO) is partnering with Vital Options International to raise awareness of cancer survivorship.
Scientific meeting in Los Angeles to highlight advances in cancer treatment.
Women with early stage breast cancer who receive a newer type of radiation called intensity modulated radiation therapy (IMRT) develop significantly fewer side effects than women who receive traditional radiation therapy, according to a study released today in the August 1 edition of the International Journal of Radiation Oncology * Biology * Physics, the official journal of ASTRO.
The American Society for Therapeutic Radiology and Oncology is pleased to announce that Randal S. Weber, M.D., F.A.C.S., has been chosen as an Honorary Member of the Society. Dr. Weber will receive his award during an awards ceremony at the 49th Annual Meeting to be held October 28 through November 1, 2007, at the Los Angeles Convention Center in Los Angeles.
The American Society for Therapeutic Radiology and Oncology is pleased to announce its 2007 class of ASTRO Fellows. These 40 distinguished members will receive their awards at a special ceremony during the 49th Annual Meeting to be held October 28 through November 1, 2007, at the Los Angeles Convention Center in Los Angeles.
Women with breast cancer who receive higher doses of radiation with IMRT each day can reduce their treatment time by two weeks without increasing side effects, according to a study released today in the June 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
In 1973, two researchers published an article in the journal Lab Investigation saying that radiation to the breast area might damage the capillaries and restrict blood flow to the heart. Since that time, conflicting reports about the long-term risk of radiation to the heart have been published. According to a study released today, elderly women who receive radiation therapy for early-stage breast cancer appear to have no increased risk of a heart attack after taking pre-existing cardiac risk factors into account. Interestingly, pre-existing cardiac risk factors such as diabetes, hypertension and hyperlipidemia do not potentiate the effects of radiation on the heart.
More than ninety percent of men who receive appropriate radiation dose levels with permanent radiation seed implants to treat their prostate cancer are cured of their cancer eight years after diagnosis, according to a study released in the February 1 issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of ASTRO.
Giving patients with head and neck cancer a combination of chemotherapy and radiation therapy controls the cancer and allows many patients to avoid additional surgery to the neck, according to a study presented at the plenary session today at the Multidisciplinary Head and Neck Cancer Symposium in Rancho Mirage, Calif., co-sponsored by the American Society for Therapeutic Radiology and Oncology.
Patients with early stage oral cancer may benefit from a more advanced screening process allowing for a more accurate diagnosis, according to a study presented at the plenary session today at the Multidisciplinary Head and Neck Cancer Symposium in Rancho Mirage, Calif., co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society of Clinical Oncology and the American Head and Neck Society.
Preliminary findings show adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer live longer, according to a study presented today at the plenary session of the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology.
The addition of Cetuximab (brand name Erbitux) to radiation therapy treatments does not increase the rate or duration of some side effects in the treatment of advanced head and neck cancers, according to a study presented at the plenary session today at the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology.
Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study released today in the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO.
Prostate cancer patients who have a temporary rise in their prostate specific antigen (PSA) levels after radiation therapy - called a PSA bounce - are not at an increased risk of their cancer coming back any more than those who don't have a temporary rise, according to the largest study of its kind presented November 8, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Hodgkin's lymphoma survivors who have lipid screening every five years to detect high cholesterol will live a half year longer than patients who don't have the screening and the intervention is cost-effective, according to a study presented November 8, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Chemoradiation (radiation and chemotherapy given at the same time) given through a needle or tube inserted into a vein (intravenous) is as effective as treatment given directly to the tumor through a tube inserted into an artery (intra-arterial) for patients with inoperable head and neck cancer, according to a randomized study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Breast cancer patients who undergo a new radiation technique called intensity modulated radiation therapy (IMRT) after surgery are three times less likely to have severe skin reactions from the treatment compared to standard radiation therapy, according to a study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Patients with lung cancer that has spread to mediastinal lymph nodes "“ located between the chest, breastbone and spine "“ who receive radiation after surgery and chemotherapy live twice as long as patients who do not receive radiation after surgery, according to a study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Doctors have created a first-ever computer tool to predict the risk of breast cancer returning in the same breast over a 10-year period in women who have had breast conserving surgery to remove only the cancer (lumpectomy), according to a study presented November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Negative perceptions about radiation therapy can strongly influence a prostate cancer patient's choice to avoid external beam radiation therapy, even though studies have proven the treatment to be as safe and effective as other treatments for the disease, including surgery, according to a study presented November 5, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Prostate cancer patients treated with either radiation or surgery who use hormone therapy for longer than six months do not survive any longer than patients who use the treatment for a shorter amount of time, according to a study presented November 5, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
The American Society for Therapeutic Radiology and Oncology has named Rita Davis-Goldsberry of Newark, Del., as the 2006 Survivor Circle Award Winner and Barbara Knight-Meyers, Ph.D., as the 2006 Distinguished Honoree. Ms. Davis-Goldsberry will be presented with her award and a $1,000 cash prize and Dr. Knight-Meyers will be presented with her award on Monday, November 6, 2006, at 1 p.m., at the Pennsylvania Convention Center.
As part of its continued efforts to give back to the cancer communities in the cities visited during its annual scientific meetings, the Fairfax, Virginia-based American Society for Therapeutic Radiology and Oncology (ASTRO) is partnering with Cancer Hope Network, to raise awareness of cancer survivorship. The Cancer Hope Network is a non-profit organization that provides one-on-one support to people undergoing treatment for cancer and to their families.
The American Society for Therapeutic Radiology and Oncology is pleased to announce the results of the recent election for open positions on the Board of Directors.
September is Prostate Cancer Awareness Month and the American Society for Therapeutic Radiology and Oncology (ASTRO) is encouraging men to get educated when it comes to prostate cancer awareness, screening and their treatment options.
Modern three-dimensional radiation therapy has been proven to be more successful at curing lung cancer than older two-dimensional radiation therapy for some patients with early stage lung cancer, according to a new study in the September 1, 2006 edition of the International Journal of Radiation Oncology, Biology and Physics.
Do Close Surgical Margins Predict If Breast Cancer Will Return? A new study published in the August 1, 2006, issue of the International Journal of Radiation Oncology * Biology * Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology, says that cancer cells present after additional surgery for breast cancer may predict whether a woman will see her cancer return.
Doctors in New England have discovered that patients receiving accelerated-partial breast radiation therapy using a balloon brachytherapy system after lumpectomy for breast cancer can develop seroma, the retaining of fluid, in their breast which can require aspiration or make monitoring them by physical exam more difficult.
Doctors have discovered that combining images derived from positron emission tomography and computed tomography in the planning and delivery of radiation treatment for patients with head and neck cancer leads to more accurate delivery of the radiation dose and an increased chance for survival.
International researchers have developed a prediction model to assist doctors in determining the chance of recurrence of cancer in high-risk breast cancer patients who have undergone a mastectomy followed by radiation therapy.
A consortium of prostate cancer experts have discovered that prostate cancer patients who have a lower prostate specific antigen (PSA) score after radiation therapy to treat their cancer are less likely to have their prostate cancer return or spread to other parts of their body.
More than 148,000 people will learn that they have colorectal cancer this year, making it the third leading cancer in both men and women in the United States. The disease can be cured and often prevented if people are screened properly.
Doctors in Brazil have concluded that the drug amifostine eases many of the most common side effects associated with patients receiving radiation therapy to treat their cancer while simultaneously making the cancer more susceptible to radiation.
The American Society for Therapeutic Radiology and Oncology is pleased to announce that TomoTherapy Inc., Varian Medical Systems, Inc., and Standard Imaging have been elected to serve three-year terms on ASTRO's Corporate Advisory Council.
Doctors in Italy are studying whether a new type of mouthwash will help alleviate pain for patients suffering from head and neck cancer who were treated with radiation therapy, according to a study.
Doctors in Canada are studying the effectiveness of permanent radiation seed implants following lumpectomy as an alternative to whole or partial breast irradiation for early-stage breast cancer patients, according to a study.
Patients suffering from advanced head and neck cancer affecting their larynx can maintain vocal function by undergoing a combination of radiation therapy and chemotherapy instead of surgery to remove the larynx, according to a study.
To help patients understand how radiation therapy works in conjunction with other treatments to cure bladder cancer, ASTRO has developed a brochure, Radiation Therapy for Bladder Cancer, that patients can use to talk with their healthcare providers when contemplating radiation therapy.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right